- Home
- CGTX vs NMS Comparison
CGTX vs NMS Comparison
Compare CGTX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- NMS
- Stock Information
- Founded
- CGTX 2007
- NMS 1993
- Country
- CGTX United States
- NMS United States
- Employees
- CGTX N/A
- NMS N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- CGTX Health Care
- NMS Finance
- Exchange
- CGTX Nasdaq
- NMS Nasdaq
- Market Cap
- CGTX 79.3M
- NMS 76.2M
- IPO Year
- CGTX 2021
- NMS N/A
- Fundamental
- Price
- CGTX $0.44
- NMS $13.30
- Analyst Decision
- CGTX Buy
- NMS
- Analyst Count
- CGTX 6
- NMS 0
- Target Price
- CGTX $8.00
- NMS N/A
- AVG Volume (30 Days)
- CGTX 476.7K
- NMS 12.0K
- Earning Date
- CGTX 11-13-2024
- NMS 01-01-0001
- Dividend Yield
- CGTX N/A
- NMS 4.11%
- EPS Growth
- CGTX N/A
- NMS N/A
- EPS
- CGTX N/A
- NMS N/A
- Revenue
- CGTX N/A
- NMS N/A
- Revenue This Year
- CGTX N/A
- NMS N/A
- Revenue Next Year
- CGTX N/A
- NMS N/A
- P/E Ratio
- CGTX N/A
- NMS N/A
- Revenue Growth
- CGTX N/A
- NMS N/A
- 52 Week Low
- CGTX $0.34
- NMS $9.21
- 52 Week High
- CGTX $2.95
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- CGTX 41.17
- NMS 53.98
- Support Level
- CGTX $0.43
- NMS $13.05
- Resistance Level
- CGTX $0.48
- NMS $13.56
- Average True Range (ATR)
- CGTX 0.04
- NMS 0.26
- MACD
- CGTX -0.01
- NMS -0.00
- Stochastic Oscillator
- CGTX 7.26
- NMS 46.05
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.